Objective: To detect the frequency and subtypes of HPV in the uterine cervix of HIVinfected women. Methods: Sample consisted of 288 HIV-infected women, recruited from the public health system of five cities of Minas Gerais, Brazil. Women were seen from August 2003 to August 2008. Cervical samples were collected for cytological analysis and for HPV DNA detection, using polymerase chain reaction (PCR). HPV DNA was classified according to its oncogenic potential in low risk (types 6, 11) and high risk (types 16, 18, 31, 33, 35). Colposcopy was performed, followed by cervical biopsy when necessary. Categorical variables were compared using the Chi-squared test, with a significance level established at the 5% level. Results: HPV prevalence was 78.8%. Most frequent genotypes were HPV-6 (63.9%) and HPV-16 (48.5%). High-risk HPV were observed in 70.5% of the women; low-risk in 71.4%; both high and low-risk HPV were detected in 55.1% of the patients. Multiple HPV genotypes were detected in 64.8% of the patients; two genotypes in 23.8%, and three in 18.9%. Conclusion: HPV prevalence was high among HIV-infected women. Multiple HPV genotypes were common in samples from the uterine cervix of HIVinfected women.
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IntroductIon
The association between cervical cancer and human immunodeficiency virus (HIV) is well established 1, 2 . Several studies have shown that HPV infection is significantly more common among HIV positive women compared to HIV negative women [3] [4] [5] [6] [7] [8] [9] [10] . The association between cervical cancer and human papillomavirus (HPV) has also been demonstrated, but the potentially modifying role of HIV on the HPV/cervical intraepithelial neoplasia association is still under investigation 11 . Current data suggest that HIV infection increases HPV persistence, with increased risk for intraepithelial cervical lesions 2, 4 . Published data strongly suggest that HIV-infected women are more likely to have HPV DNA, as well as multiple viral types and a higher frequency of the oncogenic types [6] [7] [8] . Similar findings have been reported in different regions of Brazil 9,12-14 and HPV 16 was the most frequent oncogenic type [7] [8] [9] . Polimerase chain reaction (PCR) has the highest sensitivity for detecting HPV DNA genotypes and discriminates multiples infections better than other biomolecular methods. It also has good specificity and results are quickly available 2 . The aim of this study was to estimate the prevalence of HPV DNA infection in HIV-infected women from different cities. We also aimed to investigate the prevalence of HPV genotypes, as well as the frequency of multiple types of HPV. A standardized questionnaire was used for collecting demographic, social, and behavioral characteristics of the sample, as well as for obtaining the medical history. Gynecological exam was performed and cervical samples were collected for Pap smear, as well as for HPV-DNA, by doctors from the group study to guarantee a standardized collection. Blood samples were collected to obtain T CD4+ cells count and HIV viral load. Colposcopy, biopsy and adequate treatment of cervical lesions were performed as part of the routine medical care.
Inclusion criteria were: HIV infection diagnosed by ELISA and confirmed by indirect immunofluorescence or western blot, with or without AIDS; age ≥ 18 years; consent to participate (signature of the approved informed consent form). Exclusion criteria were: difficulties in obtaining information (language barrier, disorientation); non-analyzable samples; pregnancy; history of hysterectomy.
The study protocol was approved by the UFMG Research Ethics Committee.
ProCedures
Cervical samples for DNA-HPV exams were obtained using an Ayre's spatula, and transferred to a sterile tube containing 2 mL of saline solution (0.09%). The tube was conditioned in a special box with cooled gel. The samples were sent to a reference laboratory (Núcleo de Ações e Pesquisas em Apoio Diagnóstico, Medical School, UFMG), within 24 hours of the procedure. DNA was extracted using Chelex 100 chelating resin (BioRad), according to the manufacturer's protocol 15 . Specific primers for HPV DNA types 6, 11, 16, 18, 31, 33 and 35 were tested.
PolyMerase Chain reaCtion and analysis Criteria
In order to control for DNA quality, the globin gene was amplified in all samples 16 . Globin-negative samples were excluded from the study. HPV detection by PCR was carried out in a nested-PCR system, using MY09/11 17 and GP5+/6+ 18 primers. Positive samples were tested with specific primers for HPV DNA types 6, 11, 16, 18, 31, 33 and 35, through independent reactions 15 . All products were submitted to agarose gel electrophoresis 2%, treated with ethidium bromide and analyzed under UV light. DNA was classified according to its oncogenic potential in low risk (6, 11) and high risk (16, 18, 31, 33 and 35) . statistiCal analysis Data were transferred to a specially designed database using Excel 2003. Demographic and social variables included were: age (in years) at enrollment; age of first sexual intercourse; lifetime number of sexual partners; marital status; working status; smoking; condom use; route of transmission; and drug addiction. Clinical and laboratory variables were: CDC classification (1993) 19 ; antiretroviral regimen use; colposcopy; CD4+ T-lymphocytes cell count; HIV-1 viral load. Frequency and type of HPV genotypes (6, 11, 16, 18 , 31, 33 and 35) were also analyzed.
The Epi-Info software version 3.3.2 was used for the statistical analysis. Proportions were compared with the Chi-squared test. Statistical significance was established at the 5% levels. Sample size was determined based on published findings (prevalence of HPV in HIV-infected women ranging from 52 to 87%) 9, 14 . The prevalence of 50% was used in order to obtain a minimum sample that might guarantee more precise statistical tests. To achieve 80% of power, we estimated the sample at 278 participants.
reSultS
The sample consisted of 288 women from five different cities: A (n = 152; 52.8%); B (n = 36; 12.5%); C (n = 20; 6.9%); D (n = 44; 15.3%); and E (n = 36; 12.5%). As can be seen in Figure 1 , general prevalence of HPV infection was high (78.8%) among these HIV-infected patients. There was no significant difference among HPV prevalence of women from these different cities (p = 0.19).
Median age at enrollment was 35 years; median age of first sexual intercourse was 17 years; median number of lifetime sexual partners was three. Regarding the clinical and behavioral characteristics, most participants were in a stable union (44.1%), worked at home (51.7%) and were infected through the sexual route (92.0%). Few women smoked (31.3%), used condom (42.7%) and were addicted to drugs (0.7%). Half of them had AIDS 19 and 67.7% were using antiretroviral drugs. Normal colposcopy was found in 63.2% of them. Table 1 summarizes some of the clinical and behavioral characteristics of these women.
It was detected that 151 patients presented a viral load higher than the established cut-off value of 400 copies/mL (minimum limit of detection of RNA HIV at the time of the study). Among them, in 123 (81.5%) was detected the DNA HPV. On the other hand, 119 patients had undetected viral load (≤ 400 copies/mL) and 90 (75.6%) of them presented the DNA HPV. The differences were not significant (p = 0,2441).
Furthermore, a cut in the T CD4+ cell count in 200 cells/mm³ was made based on the CDC classification of AIDS and non-AIDS 19 . Amongst 45 patients presenting T CD4+ cell count < 200 cells/mm³, 37 (82.2%) had the High-risk HPV (patient showing at least one highrisk HPV type) was observed in 70.5% (160/288) of patients; low-risk HPV (patient showing at least one low-risk HPV type) was found in 71.4% (162/288) of women; and both high and low-risk HPV were detected in 55.1% (125/288) of them. The prevalence of HPV was higher (61.7%) in patients who had three or more sexual partners. Nevertheless, this result was not significant (p = 0.8431). Table 2 displays the prevalence of each genotype as well as the proportion of women with multiple HPV genotypes. Most prevalent genotypes were HPV-6 (63.9%) and HPV-16 (48.5%). Differences emerged among cities. HPV-31 and HPV-33 genotypes were the most prevalent in City C (60% and 53.3%) and City E (24% for both). Multiple genotypes were present in 64.8% of women: two (23.8%) and three (18.9%) different genotypes were common. This table also shows that the percentage of patients with HPV which could not be typed varied from 0% to 11.1%. One of the cities (City E) presented the highest percentage of non-identified HPV (48%).
dIScuSSIon
Prevalence of HPV infection was high (78.8%) among our sample of HIV-infected patients recruited at five different cities. These findings are consisted with other studies 6, 14, 20 .
Median age (35 years old) was similar to the age of a distinct sample in Brazil 14, 21 . That suggests that HPV/HIV coinfection is common among women of reproductive age.
Although the median age for the first sexual intercourse was 17, dispersion was high and some women had first sexual intercourse as early as at the age of 10, as previously described 8 . Sexual transmission was the predominant route of HIV acquisition (92%), at higher rates than previously reported 22 .
Condom use was not a common practice, consistently used by only 42.7% of the partners. Similar percentage has been previously reported in a sample of 75 HIV-infected patients 22 . Data obtained from a metanalysis from different countries of North America, Africa, Asia, Europe and South/ Central America evaluated prevalence of HPV and genotypes among 5.578 HIV-infected patients. South and North America (Brazil and Mexico) contributed 7.8% of the sample. HPV prevalence was higher among women from Brazil and Mexico (57.3%), compared to overall findings (36.5%). According to this metanalysis, HPV prevalence was associated with advanced cervical lesion. Multiple infections were frequent, and HIV-positive patients with HPV-16 were more likely to have advanced cervical lesions 7 .
In addition, studies conducted in Brazil 9 and India 8 found that HPV-16 was the most common genotype (30.9% and 33% respectively) among HIV-infected women. We found that HPV-6 was the most prevalent genotype (63.9%), followed by HPV-16 (48.5%). Other studies found percentages ranging from 52% 6 to 87% 
